1. Home
  2. News
  3. Current Practices and...

Current Practices and Expectations of Bioburden Testing

Francesco Boschi GSK

Sorry the text on this page is not available at the moment.

Bioburden
Other Pharmaceutical

Related articles

Spore.Bio Names Dr. Michael J. Miller As VP Bolstering Scientific And Regulatory Strategy

Spore.Bio Names Dr. Michael J. Miller As VP Bolstering Scientific And Regulatory Strategy

4th February 2026
QC Microbiology for Pharmaceuticals - a rapidmicrobiology Special Focus

QC Microbiology for Pharmaceuticals - a rapidmicrobiology Special Focus

3rd February 2026

Rapid CFU Detection: Faster Results, Better Manufacturing Control

2nd February 2026
Boost Bioburden Testing Efficiency with an ISPE Award-winning Automated Solution!

Boost Bioburden Testing Efficiency with an ISPE Award-winning Automated Solution!

2nd December 2025
Total Viable Count: 24 - 48h to See Sooner and Act Faster

Total Viable Count: 24 - 48h to See Sooner and Act Faster

10th November 2025
Lonza to Expand Bioscience Testing Offering With the Acquisition of Redberry 

Lonza to Expand Bioscience Testing Offering With the Acquisition of Redberry 

27th October 2025

FILTER BY SECTOR

Diamidex legionella webinar watch now
advertisement
MBV MAS 100 Libra passive air monitoring now automated
advertisement
Enviroscreen hygiene monitoriing from Technical Service Consultants
advertisement
Boosting brand reputation
advertisement

LATEST MICROBIOLOGY NEWS

MICROBIOLOGY EVENTS

RMB LOGO

Get all the latest updates on products and services for your microbiology lab in the free weekly rapidmicrobiology newsletter - sign up now!

Contact info

  • Rapid Test Methods Ltd
  • C/O Xeinadin,
    BLDG G West Cork Technology Park,
    Clonakilty, CORK,
    Ireland P85 VF62
  • +[353] 2388 31884
  • info@rapidmicrobiology.com

Submit

rapidmicrobiology

Other sections

© 2001 - 2026 Rapid Test Methods Ltd. All rights reserved.